Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2026-02-21 @ 11:21 AM
Study NCT ID:
NCT00574132
Status:
COMPLETED
Last Update Posted:
2013-11-25
First Post:
2007-12-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Sponsor:
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ELN115727-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |